Chemed Corp (CHE) by event type
CHE moves most on analyst downgrades — a median of +0.16% at 30 minutes across 13 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the CHE overview →
How CHE reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 866 of 2,603 | 13 | +0.16% | 54% | +0.18% |
| Rating reiterations 1,845 of 3,522 | 23 | -0.00% | 48% | +0.30% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 4 further classes were observed with fewer than 10 measured events and are not published.
That’s how CHE usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Rating reiterations → · CHE overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | 290 | -0.23% | 46% |
| Accuray Incorporated (ARAY) | 288 | 0.00% | 51% |
| Fate Therapeutics, Inc. (FATE) | 287 | -0.76% | 39% |
| RenovaCare, Inc. (RCAR) | 286 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.